Arthritis Monoclonal Antibodies Market Report

1.1 Product Definition and Scope

1.2 PEST (Political, Economic, Social and Technological) Analysis of Arthritis Monoclonal Antibodies Market

1.3 Market Segment by Type

1.3.1 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Remicade from 2016 to 2027

1.3.2 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Humira from 2016 to 2027

1.3.3 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Enbrel from 2016 to 2027

1.3.4 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Rituxan from 2016 to 2027

1.3.5 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Orencia from 2016 to 2027

1.3.6 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Actemra from 2016 to 2027

1.3.7 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Simponi from 2016 to 2027

1.3.8 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Cimzia from 2016 to 2027

1.4 Market Segment by Application

1.4.1 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Rheumatoid Arthritis from 2016 to 2027

1.4.2 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Osteoarthritis from 2016 to 2027

1.4.3 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Psoriatic Arthritis from 2016 to 2027

1.4.4 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Ankylosing Spondylitis from 2016 to 2027

1.4.5 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Fibromyalgia from 2016 to 2027

1.4.6 China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Others from 2016 to 2027

1.5 Market Segment by Regions

2.1 Market Trends and Dynamics

2.2 Competitive Landscape Analysis

2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

3.1 Products Development Trends of Different Types

3.2 Commercial Products Types of Major Vendors

3.3 Competitive Landscape Analysis of Different Types

3.4 Market Size of Arthritis Monoclonal Antibodies by Major Types

3.4.1 Market Size and Growth Rate of Remicade

3.4.2 Market Size and Growth Rate of Humira

3.4.3 Market Size and Growth Rate of Enbrel

3.4.4 Market Size and Growth Rate of Rituxan

3.4.5 Market Size and Growth Rate of Orencia

3.4.6 Market Size and Growth Rate of Actemra

3.4.7 Market Size and Growth Rate of Simponi

3.4.8 Market Size and Growth Rate of Cimzia

4.1 Downstream Client Analysis by End-Users

4.2 Competitive Landscape Analysis of Different End-Users

4.3 Market Potential Analysis of Different End-Users

4.4 Market Size of Arthritis Monoclonal Antibodies by Major End-Users

4.4.1 Market Size and Growth Rate of Arthritis Monoclonal Antibodies in Rheumatoid Arthritis

4.4.2 Market Size and Growth Rate of Arthritis Monoclonal Antibodies in Osteoarthritis

4.4.3 Market Size and Growth Rate of Arthritis Monoclonal Antibodies in Psoriatic Arthritis

4.4.4 Market Size and Growth Rate of Arthritis Monoclonal Antibodies in Ankylosing Spondylitis

4.4.5 Market Size and Growth Rate of Arthritis Monoclonal Antibodies in Fibromyalgia

4.4.6 Market Size and Growth Rate of Arthritis Monoclonal Antibodies in Others

5.1 China Arthritis Monoclonal Antibodies Production Analysis by Regions

5.2 China Arthritis Monoclonal Antibodies Consumption Analysis by Regions

5.3 Coronavirus (COVID-19) Impact on China Economy

6.1 North China Arthritis Monoclonal Antibodies Landscape Analysis by Major Types

6.2 North China Arthritis Monoclonal Antibodies Landscape Analysis by Major End-Users

7.1 Central China Arthritis Monoclonal Antibodies Landscape Analysis by Major Types

7.2 Central China Arthritis Monoclonal Antibodies Landscape Analysis by Major End-Users

8.1 South China Arthritis Monoclonal Antibodies Landscape Analysis by Major Types

8.2 South China Arthritis Monoclonal Antibodies Landscape Analysis by Major End-Users

9.1 East China Arthritis Monoclonal Antibodies Landscape Analysis by Major Types

9.2 East China Arthritis Monoclonal Antibodies Landscape Analysis by Major End-Users

10.1 Northeast China Arthritis Monoclonal Antibodies Landscape Analysis by Major Types

10.2 Northeast China Arthritis Monoclonal Antibodies Landscape Analysis by Major End-Users

11.1 Southwest China Arthritis Monoclonal Antibodies Landscape Analysis by Major Types

11.2 Southwest China Arthritis Monoclonal Antibodies Landscape Analysis by Major End-Users

12.1 Northwest China Arthritis Monoclonal Antibodies Landscape Analysis by Major Types

12.2 Northwest China Arthritis Monoclonal Antibodies Landscape Analysis by Major End-Users

13.1 GSK

13.2 Novartis

13.3 Mylan

13.4 Johnson & Johnson(Janssen)

13.5 F Hoffmann-La Roche Ltd

13.6 AbbVie Inc

13.7 Pfizer Inc

13.8 AstraZeneca PLC

13.9 Genentech

Figure Product Picture

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Remicade from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Humira from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Enbrel from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Rituxan from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Orencia from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Actemra from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Simponi from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Cimzia from 2016 to 2027

Figure Market Share by Type in 2016

Figure Market Share by Type in 2021

Figure Market Share by Type in 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Rheumatoid Arthritis from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Osteoarthritis from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Psoriatic Arthritis from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Ankylosing Spondylitis from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Fibromyalgia from 2016 to 2027

Figure China Arthritis Monoclonal Antibodies Market Size and Growth Rate of Others from 2016 to 2027

Figure Market Share by End-User in 2016

Figure Market Share by End-User in 2021

Figure Market Share by End-User in 2027

Figure North China Arthritis Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027

Figure Central China Arthritis Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027

Figure South China Arthritis Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027

Figure East China Arthritis Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northeast China Arthritis Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027

Figure Southwest China Arthritis Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027

Figure Northwest China Arthritis Monoclonal Antibodies Consumption Market Size and Growth Rate from 2016 to 2027

Figure Development Trends and Industry Dynamics of Arthritis Monoclonal Antibodies Industry

Figure Market Challenges and Restraints

Figure Market Opportunities and Potentials

Table Mergers and Acquisition

Figure Market Share of TOP 3 Players in 2020

Figure Market Share of TOP 5 Players in 2021

Figure Market Share of TOP 6 Players from 2016 to 2021

Figure Porter's Five Forces Analysis

Figure New Entrant SWOT Analysis

Figure Coronavirus (COVID-19) Map of China

Table Coronavirus (COVID-19) Impact on the Industry

Figure Specifications of Different Types of Arthritis Monoclonal Antibodies

Figure Development Trends of Different Types

Table Commercial Products Types of Major Vendors

Figure Competitive Landscape Analysis of Different Types

Table Consumption of Arthritis Monoclonal Antibodies by Different Types from 2016 to 2027

Table Consumption Share of Arthritis Monoclonal Antibodies by Different Types from 2016 to 2027

Figure Market Size and Growth Rate of Remicade

Figure Market Size and Growth Rate of Humira

Figure Market Size and Growth Rate of Enbrel

Figure Market Size and Growth Rate of Rituxan

Figure Market Size and Growth Rate of Orencia

Figure Market Size and Growth Rate of Actemra

Figure Market Size and Growth Rate of Simponi

Figure Market Size and Growth Rate of Cimzia

Table Downstream Client Analysis by End-Users

Figure Competitive Landscape Analysis of Different End-Users

Table Market Potential Analysis of Different End-Users

Figure Consumption of Arthritis Monoclonal Antibodies by Different End-Users from 2016 to 2027

Table Consumption Share of Arthritis Monoclonal Antibodies by Different End-Users from 2016 to 2027

Figure Market Size and Growth Rate of Rheumatoid Arthritis

Figure Market Size and Growth Rate of Osteoarthritis

Figure Market Size and Growth Rate of Psoriatic Arthritis

Figure Market Size and Growth Rate of Ankylosing Spondylitis

Figure Market Size and Growth Rate of Fibromyalgia

Figure Market Size and Growth Rate of Others

Table China Arthritis Monoclonal Antibodies Production by Regions

Table China Arthritis Monoclonal Antibodies Production Share by Regions

Figure China Arthritis Monoclonal Antibodies Production Share by Regions in 2016

Figure China Arthritis Monoclonal Antibodies Production Share by Regions in 2021

Figure China Arthritis Monoclonal Antibodies Production Share by Regions in 2027

Table China Arthritis Monoclonal Antibodies Consumption by Regions

Table China Arthritis Monoclonal Antibodies Consumption Share by Regions

Figure China Arthritis Monoclonal Antibodies Consumption Share by Regions in 2016

Figure China Arthritis Monoclonal Antibodies Consumption Share by Regions in 2021

Figure China Arthritis Monoclonal Antibodies Consumption Share by Regions in 2027

Table North China Arthritis Monoclonal Antibodies Consumption by Types from 2016 to 2027

Table North China Arthritis Monoclonal Antibodies Consumption Share by Types from 2016 to 2027

Figure North China Arthritis Monoclonal Antibodies Consumption Share by Types in 2016

Figure North China Arthritis Monoclonal Antibodies Consumption Share by Types in 2021

Figure North China Arthritis Monoclonal Antibodies Consumption Share by Types in 2027

Table North China Arthritis Monoclonal Antibodies Consumption by End-Users from 2016 to 2027

Table North China Arthritis Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027

Figure North China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2016

Figure North China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2021

Figure North China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2027

Table Central China Arthritis Monoclonal Antibodies Consumption by Types from 2016 to 2027

Table Central China Arthritis Monoclonal Antibodies Consumption Share by Types from 2016 to 2027

Figure Central China Arthritis Monoclonal Antibodies Consumption Share by Types in 2016

Figure Central China Arthritis Monoclonal Antibodies Consumption Share by Types in 2021

Figure Central China Arthritis Monoclonal Antibodies Consumption Share by Types in 2027

Table Central China Arthritis Monoclonal Antibodies Consumption by End-Users from 2016 to 2027

Table Central China Arthritis Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027

Figure Central China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2016

Figure Central China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2021

Figure Central China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2027

Table South China Arthritis Monoclonal Antibodies Consumption by Types from 2016 to 2027

Table South China Arthritis Monoclonal Antibodies Consumption Share by Types from 2016 to 2027

Figure South China Arthritis Monoclonal Antibodies Consumption Share by Types in 2016

Figure South China Arthritis Monoclonal Antibodies Consumption Share by Types in 2021

Figure South China Arthritis Monoclonal Antibodies Consumption Share by Types in 2027

Table South China Arthritis Monoclonal Antibodies Consumption by End-Users from 2016 to 2027

Table South China Arthritis Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027

Figure South China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2016

Figure South China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2021

Figure South China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2027

Table East China Arthritis Monoclonal Antibodies Consumption by Types from 2016 to 2027

Table East China Arthritis Monoclonal Antibodies Consumption Share by Types from 2016 to 2027

Figure East China Arthritis Monoclonal Antibodies Consumption Share by Types in 2016

Figure East China Arthritis Monoclonal Antibodies Consumption Share by Types in 2021

Figure East China Arthritis Monoclonal Antibodies Consumption Share by Types in 2027

Table East China Arthritis Monoclonal Antibodies Consumption by End-Users from 2016 to 2027

Table East China Arthritis Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027

Figure East China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2016

Figure East China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2021

Figure East China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2027

Table Northeast China Arthritis Monoclonal Antibodies Consumption by Types from 2016 to 2027

Table Northeast China Arthritis Monoclonal Antibodies Consumption Share by Types from 2016 to 2027

Figure Northeast China Arthritis Monoclonal Antibodies Consumption Share by Types in 2016

Figure Northeast China Arthritis Monoclonal Antibodies Consumption Share by Types in 2021

Figure Northeast China Arthritis Monoclonal Antibodies Consumption Share by Types in 2027

Table Northeast China Arthritis Monoclonal Antibodies Consumption by End-Users from 2016 to 2027

Table Northeast China Arthritis Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027

Figure Northeast China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2016

Figure Northeast China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2021

Figure Northeast China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2027

Table Southwest China Arthritis Monoclonal Antibodies Consumption by Types from 2016 to 2027

Table Southwest China Arthritis Monoclonal Antibodies Consumption Share by Types from 2016 to 2027

Figure Southwest China Arthritis Monoclonal Antibodies Consumption Share by Types in 2016

Figure Southwest China Arthritis Monoclonal Antibodies Consumption Share by Types in 2021

Figure Southwest China Arthritis Monoclonal Antibodies Consumption Share by Types in 2027

Table Southwest China Arthritis Monoclonal Antibodies Consumption by End-Users from 2016 to 2027

Table Southwest China Arthritis Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027

Figure Southwest China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2016

Figure Southwest China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2021

Figure Southwest China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2027

Table Northwest China Arthritis Monoclonal Antibodies Consumption by Types from 2016 to 2027

Table Northwest China Arthritis Monoclonal Antibodies Consumption Share by Types from 2016 to 2027

Figure Northwest China Arthritis Monoclonal Antibodies Consumption Share by Types in 2016

Figure Northwest China Arthritis Monoclonal Antibodies Consumption Share by Types in 2021

Figure Northwest China Arthritis Monoclonal Antibodies Consumption Share by Types in 2027

Table Northwest China Arthritis Monoclonal Antibodies Consumption by End-Users from 2016 to 2027

Table Northwest China Arthritis Monoclonal Antibodies Consumption Share by End-Users from 2016 to 2027

Figure Northwest China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2016

Figure Northwest China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2021

Figure Northwest China Arthritis Monoclonal Antibodies Consumption Share by End-Users in 2027

Table Company Profile and Development Status of GSK

Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

Figure Sales and Growth Rate Analysis of GSK

Figure Revenue and Market Share Analysis of GSK

Table Product and Service Introduction of GSK

Table Company Profile and Development Status of Novartis

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

Figure Sales and Growth Rate Analysis of Novartis

Figure Revenue and Market Share Analysis of Novartis

Table Product and Service Introduction of Novartis

Table Company Profile and Development Status of Mylan

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

Figure Sales and Growth Rate Analysis of Mylan

Figure Revenue and Market Share Analysis of Mylan

Table Product and Service Introduction of Mylan

Table Company Profile and Development Status of Johnson & Johnson(Janssen)

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson(Janssen)

Figure Sales and Growth Rate Analysis of Johnson & Johnson(Janssen)

Figure Revenue and Market Share Analysis of Johnson & Johnson(Janssen)

Table Product and Service Introduction of Johnson & Johnson(Janssen)

Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

Table Product and Service Introduction of F Hoffmann-La Roche Ltd

Table Company Profile and Development Status of AbbVie Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie Inc

Figure Sales and Growth Rate Analysis of AbbVie Inc

Figure Revenue and Market Share Analysis of AbbVie Inc

Table Product and Service Introduction of AbbVie Inc

Table Company Profile and Development Status of Pfizer Inc

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

Figure Sales and Growth Rate Analysis of Pfizer Inc

Figure Revenue and Market Share Analysis of Pfizer Inc

Table Product and Service Introduction of Pfizer Inc

Table Company Profile and Development Status of AstraZeneca PLC

Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca PLC

Figure Sales and Growth Rate Analysis of AstraZeneca PLC

Figure Revenue and Market Share Analysis of AstraZeneca PLC

Table Product and Service Introduction of AstraZeneca PLC

Table Company Profile and Development Status of Genentech

Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech

Figure Sales and Growth Rate Analysis of Genentech

Figure Revenue and Market Share Analysis of Genentech

Table Product and Service Introduction of Genentech